Voxel-Based Analysis of the Relation of 3′-Deoxy-3′-[18F]fluorothymidine ([18F]FLT) PET and Diffusion-Weighted (DW) MR Signals in Subcutaneous Tumor Xenografts Does Not Reveal a Direct Spatial Relation of These Two Parameters

[1]  A. Hansen,et al.  18F-fluorothymidine (FLT)-PET and diffusion-weighted MRI for early response evaluation in patients with small cell lung cancer: a pilot study , 2020, European Journal of Hybrid Imaging.

[2]  Evis Sala,et al.  How clinical imaging can assess cancer biology , 2019, Insights into Imaging.

[3]  J. Griffiths,et al.  Thymidine Metabolism as a Confounding Factor for 3′-Deoxy-3′-18F-Fluorothymidine Uptake After Therapy in a Colorectal Cancer Model , 2018, The Journal of Nuclear Medicine.

[4]  C. Geppert,et al.  Voxelwise analysis of simultaneously acquired and spatially correlated 18F‐fluorodeoxyglucose (FDG)‐PET and intravoxel incoherent motion metrics in breast cancer , 2017, Magnetic resonance in medicine.

[5]  S. Brady,et al.  Dose optimization: a review of CT imaging for PET attenuation correction , 2017, Clinical and Translational Imaging.

[6]  A. Bergmann,et al.  Killers creating new life: caspases drive apoptosis-induced proliferation in tissue repair and disease , 2017, Cell Death and Differentiation.

[7]  S. Vajapeyam,et al.  Correlation of 18F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium , 2017, The Journal of Nuclear Medicine.

[8]  Yan Liu,et al.  Preclinical Applications of 3'-Deoxy-3'-[18F]Fluorothymidine in Oncology - A Systematic Review , 2017, Theranostics.

[9]  J. Griffiths,et al.  Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3'-Deoxy-3'-[18F]Fluorothymidine in Preclinical Models of Lung Cancer. , 2016, Cancer research.

[10]  H. Schmidt,et al.  The Synergistic Effect of Selumetinib/Docetaxel Combination Therapy Monitored by [18 F]FDG/[18 F]FLT PET and Diffusion-Weighted Magnetic Resonance Imaging in a Colorectal Tumor Xenograft Model , 2016, Molecular Imaging and Biology.

[11]  W. Oyen,et al.  A systematic review on [(18)F]FLT-PET uptake as a measure of treatment response in cancer patients. , 2016, European journal of cancer.

[12]  Ernst J. Rummeny,et al.  Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis , 2015, PloS one.

[13]  Chuan-Yuan Li,et al.  Cell death-stimulated cell proliferation: a tissue regeneration mechanism usurped by tumors during radiotherapy. , 2013, Seminars in radiation oncology.

[14]  C. Claussen,et al.  Correlation of Simultaneously Acquired Diffusion-Weighted Imaging and 2-Deoxy-[18F] fluoro-2-D-glucose Positron Emission Tomography of Pulmonary Lesions in a Dedicated Whole-Body Magnetic Resonance/Positron Emission Tomography System , 2013, Investigative radiology.

[15]  Ralph Sinkus,et al.  Apparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug development. , 2012, European journal of cancer.

[16]  C. Meyer,et al.  Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Bradford A Moffat,et al.  Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Schmidt,et al.  Quantitative correlation at the molecular level of tumor response to docetaxel by multimodal diffusion-weighted magnetic resonance imaging and [¹⁸F]FDG/[¹⁸F]FLT positron emission tomography. , 2014, Molecular imaging.